Kalydeco drug cleared for cystic fibrosis patients

Minister for Health James Reilly has announced that the Government has approved the cystic fibrosis drug Kalydeco for use in Ireland from 1 March.

The National Centre for Pharmacoeconomics recently recommended against its sanction for use at a cost of more than €234,000 per patient per year.

Further discussions with the manufactures have resulted in significant savings in the cost.

The drug can lead to significant improvements for patients with a particular mutation of cystic fibrosis.

It is understood that around 120 people will benefit from the announcement.

The drug will cost in excess of €20m per annum.

Anda sedang membaca artikel tentang

Kalydeco drug cleared for cystic fibrosis patients

Dengan url

http://newsdeadlineup.blogspot.com/2013/02/kalydeco-drug-cleared-for-cystic.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Kalydeco drug cleared for cystic fibrosis patients

namun jangan lupa untuk meletakkan link

Kalydeco drug cleared for cystic fibrosis patients

sebagai sumbernya